A Bioequivalence Study of HS-20094 Multi-dose Pre-filled Injection and HS-20094 Single-dose Pre-filled Injection in Overweight or Obese Participants
Latest Information Update: 23 Jul 2025
At a glance
- Drugs HS 20094 (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- Sponsors Jiangsu Hansoh Pharmaceutical
Most Recent Events
- 23 Jul 2025 New trial record